Veliflapon | m-entrepreneurship.com

Product Name :
Veliflapon

Search keywords :
Veliflapon

drugId :
null

Target Vo:
5-lipoxygenase activating protein

Target Vo Short Name :
ALOX5AP

Moa_Name:
5-lipoxygenase activating protein inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bayer AG

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Acute Coronary Syndrome

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IKK alpha + IKK beta Antibody
KAP1 Antibody
Phospho-PERK (Thr980) Antibody: Phospho-PERK (Thr980) Antibody is an unconjugated, approximately 119 kDa, rabbit-derived, anti-PERK (Thr980) polyclonal antibody. Phospho-PERK (Thr980) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, rabbit background without labeling.

Author: Betaine hydrochloride

Related Posts